Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2015
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
Cannabis Science Enters Select, New High-Dosage Product Line of CBD, Sativa, and Indica Capsules Into the Industry-Famous Emerald Cup Event This Weekend in Santa Rosa, CA
10-12-15
Cannabis Science Releases Cannabinoid-Formulated Capsule Product Line in California; Initial Capsule Formulations Released Are CBD, Indica, and Sativa
30-11-16
Analyst Initiates Coverage on Cannabis Science w/ Accumulate Recommendation and $0.10 PPS Target as Company Advances Additional Product Lines in California and Gears Up for Animal Healthcare Entry Through Equi-Pharm
24-11-15
Cannabis Science Recaps "Your Money's Worth" Radio Interview: The Company Spoke of Its Market Prioritization, Progress to-Date, and Strategic Planning Moving Forward
21-11-15
With Product & Market Testing Completed, Cannabis Science Set to Release Seven Cannabinoid-Based Animal Care Products Through Its Wholly Owned Subsidiary, Equi-Pharm, LLC
11-11-15
Cannabis Science to Begin Its Drug Development Program With IGXBio and Its GenePro®, DNA-Based Immunotherapeudic, FDA IND # Approved
02-11-15
Cannabis Science, Inc. Takes Final Steps by Filing Dividend Paperwork With FINRA, While It Transitions Into the Equi-Pharm Acquisition and Its New Product Offerings
30-10-15
Cannabis Science Positions Itself to Issue Dividend Payouts to Its Shareholders
28-10-15
CBIS Appoints the Son of the Legendary Pan-Africanist, Marcus Garvey, Internationally Accredited Cardiovascular Surgeon Dr. Julius Garvey to Both Scientific & New International Governmental Affairs Boards
15-10-15
Recent National Cancer Institute Cannabis Reports Encourages Cannabis Science to Ramp Up California Product Releases, Bring More Products to Market in State by State Regulated Markets and Expedite Its Formal FDA Cancer Initiatives Much Faster
28-09-15
Start
Prev
1
2
3
4
5
Next
End